2007 February 8, Jeremy Pearce, “Leon J. Thal, Neurologist Who Led Study for Alzheimer’s Drugs, Dies at 62”, inNew York Times[1]:
In the 1980s, Dr. Thal, a neurologist, helped lead successful clinical trials oftacrine, a cholinesterase inhibitor drug that was approved by the Food and Drug Administration in 1993.
